OVERVIEW -
The UK Competition and Markets Authority (“CMA”) has recently published a decision accepting commitments from Vifor Pharma (“Vifor”). This brings to a close an unprecedented abuse of dominance investigation...more
The recent change in leaders in both the United States and Europe has already had a notable impact on the antitrust landscape. Rules are changing—or, at least, their enforcement is taking more novel interpretations—against a...more